Home/KnolSights/Merger and Acquisitions/Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
June 10, 2025

Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease

Abstract
Publication Reports